Encompass Health Corp financial data

Symbol
EHC on NYSE
Location
9001 Liberty Parkway, Birmingham, AL
State of incorporation
DE
Fiscal year end
December 31
Former names
HEALTHSOUTH CORP (to 12/12/2017), HEALTHSOUTH REHABILITATION CORP (to 6/22/1994)
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 118 % -7.05%
Debt-to-equity 199 % -20.6%
Return On Equity 17.7 % +4.86%
Return On Assets 7.12 % +19.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 101M shares +0.57%
Entity Public Float 8.5B USD +26.9%
Common Stock, Value, Issued 1.2M USD 0%
Weighted Average Number of Shares Outstanding, Basic 99.9M shares +0.4%
Weighted Average Number of Shares Outstanding, Diluted 102M shares +0.89%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 5.37B USD +11.9%
General and Administrative Expense 209M USD +3.72%
Costs and Expenses 4.51B USD +10.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 750M USD +23.5%
Income Tax Expense (Benefit) 150M USD +13.6%
Net Income (Loss) Attributable to Parent 456M USD +29.5%
Earnings Per Share, Basic 4.53 USD/shares +29.1%
Earnings Per Share, Diluted 4.46 USD/shares +28.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 85.4M USD +23.6%
Accounts Receivable, after Allowance for Credit Loss, Current 593M USD -1.13%
Other Assets, Current 123M USD +34.1%
Assets, Current 887M USD +5.36%
Operating Lease, Right-of-Use Asset 204M USD -2.3%
Intangible Assets, Net (Excluding Goodwill) 298M USD +7.05%
Goodwill 1.28B USD +0.21%
Other Assets, Noncurrent 219M USD +14.4%
Assets 6.53B USD +7.08%
Accounts Payable, Current 171M USD +0.59%
Employee-related Liabilities, Current 228M USD +9.83%
Liabilities, Current 841M USD +28.1%
Long-term Debt and Lease Obligation 2.36B USD -12.2%
Deferred Income Tax Liabilities, Net 105M USD +20.9%
Operating Lease, Liability, Noncurrent 190M USD -3.26%
Other Liabilities, Noncurrent 51.8M USD +12.4%
Liabilities 3.69B USD -3.15%
Retained Earnings (Accumulated Deficit) 797M USD +96%
Stockholders' Equity Attributable to Parent 2.07B USD +25.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2.79B USD +23.8%
Liabilities and Equity 6.53B USD +7.08%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 228M USD +4.11%
Net Cash Provided by (Used in) Financing Activities -40.6M USD +30%
Net Cash Provided by (Used in) Investing Activities -130M USD -24.7%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 116M shares +0.54%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 68.5M USD +3.95%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 123M USD +18.1%
Deferred Tax Assets, Valuation Allowance 21M USD -26.1%
Deferred Tax Assets, Gross 116M USD -4.76%
Operating Lease, Liability 216M USD -1.91%
Payments to Acquire Property, Plant, and Equipment 96.6M USD -14.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 456M USD +29.5%
Lessee, Operating Lease, Liability, to be Paid 297M USD -1.13%
Operating Lease, Liability, Current 26.3M USD +9.13%
Lessee, Operating Lease, Liability, to be Paid, Year Two 39.6M USD +1.02%
Lessee, Operating Lease, Liability, to be Paid, Year One 38.9M USD +5.14%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 6.5M USD +62.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 80.8M USD +1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 37.7M USD +0.8%
Deferred Tax Assets, Operating Loss Carryforwards 8.8M USD -61.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 36.7M USD +3.09%
Additional Paid in Capital 1.85B USD +3.36%
Depreciation, Depletion and Amortization 300M USD +9.38%
Deferred Tax Assets, Net of Valuation Allowance 95M USD +1.71%
Interest Expense 142M USD -17.5%